chrisvoncsefalvay/vaers-outcomes huggingface dataset:
So I got the vaccine 12/17/2021 the next day I was fine. I woke up Sunday morning with extreme lower back pain and uterine cramping. The lower back pain went up my spine to mid back. My old injury it has never gone up that far. I felt really unstable like my spine was not happy. That whole next week up to the holiday, I iced and used Tylenol and Advil alternating and took it easy. On the holiday morning I woke up with my period and it was more intense that normal. It usually lasts 3 days and lasted 5 days. I went on vacation my back pain persisted but my period stopped. Normally my back pain stops after my period stops. I was not able to see my doctor until I came back from vacation on 1/20/2022. I got an x-ray and MRI and she wanted to compare to my old injury. It showed two new injuries that showed two herniated discs that were higher up. All the way up to about 3/15/2022 I had the back pain. I did start on physical therapy for 2 days a week to strengthen my core. The disc pain went away but my lower back pain continued. The discs are still herniated.
Pt vaccinated /w PROHIBIT developed generalized urticarial rxn & local swelling/induration @ inject site. Began 12-14 hrs /p shot. Later developed some bruising ie Erythema multiforme type rxn, 2 wk following developed E. Mult rash  again
Breakthrough case admission after three vaccines 3/4/21 Pfizer Lot# ER8733 5/4/21 Pfizer Lot# EW0176 01/14/22 Pfizer Lot# 330368D
Severe rash/ diagnosed with shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient (pt.) of unknown age.  Information regarding medical history, concurrent conditions and concomitant medications was not provided.  On or about 03-MAR-2016, the patient was inoculated with zoster vaccine live (ZOSTAVAX) at a pharmacy for its intended purpose: the prevention of shingles. Shortly thereafter, the pt suffered a severe rash. Later, the pt presented on a medical center for this injury and was diagnosed with shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), pt's symptoms have resulted in physical limitations not present prior to using the vaccine. The pt sustained severe and permanent personal injuries. The reporter considered the herpes zoster to be related to Zoster Vaccine Live(ZOSTAVAX).
Information has been received from a certified medical assistant concerning an 81 year old male patient with hypertension, high cholesterol, gastrooesophageal reflux disease (GERD) and no drug reactions or allergies who on 10-FEB-2011 was vaccinated with the first dose of ZOSTAVAX (Merck) (Lot # 665530/0697Z, expire date 28-APR-2011), 0.65 ml, subcutaneously. Concomitant therapy included CELEBREX, NEXIUM, VIREAD, LOPID, COLACE, loratadine (MSD) and AZOR. Certified medical assistant stated that on 16-FEB-2011, the patient developed herpes on his left flank and was seen in the office in 17-FEB-2011. The patient was given acyclovir 800 mg 5 times a day for 5 days and hydrocortisone cream 0.1%. There were no laboratory diagnostics studies performed. At the time of the report, the patient had not recovered. Additional information has been requested.
Patient developed unexplained bilateral bruising behind both knees eight days following vaccination. Does not have a history of bruising so visibly nor a history of blood clots. Bruises started off very red, slightly itchy and scattered. Over the next few days, the bruises darkened purple and merged closer together. Bruising was much more severe on the left leg than the right.  Bruising has become less apparent over time.
Shingles on left side trigeminal nerve with headaches, rash and swollen left eye, swelling in nymph nodes
Chronic spontaneous urticaria all over body.  Have never had an allergic reaction to anything, now am covered in itchy wheals and hives.  Have been on steroids and antihistamines
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-Jul-2022; No adverse event; The patient administered the vaccine after the 30 days by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-Jul-2022).    No concomitant product use was reported. Patient received half dose. The vial had not undergone any temperature excursions. No treatment information was provided.
Dizziness, Nausea, Fainting/Syncope. BP checked 98/60 L Patient advised she did not eat prior to vaccine. Patient was instructed to set on floor. Patient was eventually moved to bed/table and instructed to lay down. Patient was assisted with the above: time/request. Patient left office at 9:40 AM. Per patient she started period today.
Pt reported feeling unusually hot and diaphoretic about 2 hours after receiving vaccine.  Blood pressure was running high with reports of 164/92, 169/102, 144/98 and then 135/89.  Taken 10 minutes apart each time.  Healthcare staff provided patient water and monitored during event.  Began to feel normal again as bp went down.  HR stayed between 69-79 during entire time.
Experienced heart racing for 2 days after each dose/After second dose - heart was racing faster and felt more severe; Most significant was after the second pfizer. Had trouble getting heart rate down.; Had difficulty catching breath; Couldn't wake up from sleep to take medicine.; This is a spontaneous report from a contactable consumer. A 32-years-old female patient received bnt162b2 (BNT162B2; Batch/Lot Number: FA7485), via an unspecified route of administration, administered in Arm Right on 12Jul2021(at the age of 32 years) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included food allergy from an unknown date and unknown if ongoing. Concomitant medications included acetylsalicylic acid (ASPRIN); ibuprofen (MOTRIN); tretinoin; minoxidil (ROGAINE); convallaria majalis, crataegus laevigata, proxyphylline (OMEGA ). Known allergies included triple antibiotics (neosporin), cranberrys. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, has the patient has not been tested for COVID-19. The patient previously took neosporine and experienced drug hypersensitivity. Historical vaccine included first dose of bnt162b2(Batch/lot number: FA6780), via an unspecified route of administration, administered in right arm on 12Jul2021 10:00 AM for covid-19 immunisation and experienced palpitations. The patient experienced experienced heart racing for 2 days after each dose/after second dose - heart was racing faster and felt more severe on 13Jul2021 13:00, had difficulty catching breath on 12Jul2021 10:30, couldn't wake up from sleep to take medicine on 12Jul2021 10:30, most significant was after the second pfizer. had trouble getting heart rate down on 13Jul2021 13:00. The patient underwent lab tests and procedures which included heart rate: decreased on 13Jul2021. The outcome of the events was recovered on an unspecified date in Jul2021.  Follow-up attempts are completed. No further information is expected.
Left Arm now has a large, very red, swollen painful lump, arm is stiff, sore & painful to even have clothes touching injection site. Can feel the heat at the injection site thru my shirt.
Was called to room where client was found to be  clammy, flushed, then turned white as a sheet, had n/v, shortness of breath, and difficulty breathing with in 10 to 15 minutes of the time the injections were given. Advised to call 911. Flu and pneumonia immunizations were given at the same time.  Epinephrine 1:1000 0.50 ml given IM and Benadryl 50mg (1.0ml) given IM. 12/19/08-records received-presented to Ed with C/O nausea and vomiting on 11/13/08. C/O pain in subxiphoid area of stomach, crampy. DX:adverse reaction to flu shot. Acute nausea and vomiting.
Pt was admitted to the hospital on 8/22/21 with acute onset of L arm numbness and mild weakness and blurred vision and diagnosed with an acute cryptogenic embolic R sided parietal lobe stroke. Pt with no risk factors and is on no medications prior. He has no history of atrial fibrillation, has never smoked tobacco, no hx of hypertension, has normal BMI. He received his covid 19 vaccines in March and April 2021.
injection site tenderness; Hot; injection site redness; injection site bump/raised circular area; Wrong Route of Administration; This case was reported by a other health professional via call center representative and described the occurrence of injection site erythema in a 58-year-old female patient who received Herpes zoster (Shingrix) (batch number 7447A, expiry date 25th April 2020) for prophylaxis.   On 14th May 2019 16:00, the patient received the 1st dose of Shingrix .5 ml. On 14th May 2019, unknown after receiving Shingrix, the patient experienced vaccine administered at inappropriate site. On 14th May 2019 19:00, the patient experienced injection site erythema and injection site swelling. On 15th May 2019, the patient experienced injection site tenderness and injection site warmth. The patient was treated with ibuprofen (Advil). On an unknown date, the outcome of the injection site erythema, injection site swelling, injection site tenderness and injection site warmth were not recovered/not resolved and the outcome of the vaccine administered at inappropriate site was unknown.   It was unknown if the reporter considered the injection site erythema, injection site swelling, injection site tenderness and injection site warmth to be related to Shingrix.  Additional details were reported as follows: The dose was given around 4:00 pm and was documented as being given in left deltoid. The medical assistant on the line reporting a patient was given Shingrix incorrectly. The medical assistant that administered it gave it half way down the patient's arm, it was too low which led to vaccine administered at inappropriate site. There was redness and a bump that developed around 7:00 pm the night of the injection and it was growing larger.  That night it was around 1 inch in diameter and the next morning it was around 3 inches.  The night it started, the patient held ice to it and took Advil.  The area was getting hotter and was really tender.  The patient returned the day of reporting and it was very hot with a pretty large red raised circular area.  The outcome reported for all AES in the structured field is RECOVERING/RESOLVING instead of not resolved (outcome uploaded)
still itchy; arm was swollen for a couple of days; she started feeling extremely heavy and strange; Her blood pressure was a little high; she feels weird; This spontaneous case was reported by a nurse and describes the occurrence of PRURITUS (still itchy), LIMB DISCOMFORT (she started feeling extremely heavy and strange), HYPERTENSION (Her blood pressure was a little high), FEELING ABNORMAL (she feels weird) and PERIPHERAL SWELLING (arm was swollen for a couple of days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic. Concomitant products included ESTRADIOL (ESTROGEN) for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced LIMB DISCOMFORT (she started feeling extremely heavy and strange), HYPERTENSION (Her blood pressure was a little high) and FEELING ABNORMAL (she feels weird). On an unknown date, the patient experienced PRURITUS (still itchy) and PERIPHERAL SWELLING (arm was swollen for a couple of days). At the time of the report, PRURITUS (still itchy), LIMB DISCOMFORT (she started feeling extremely heavy and strange), HYPERTENSION (Her blood pressure was a little high), FEELING ABNORMAL (she feels weird) and PERIPHERAL SWELLING (arm was swollen for a couple of days) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Blood pressure measurement: 155/102 (High) 155/102, 171/110 (High) 171/110 and 180/115 (High) 180/115.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient called her cardiologist who suggested she takes her blood pressure medication right away and then at regular time. She even called the poison control and they told her to double up her dose of blood pressure medication before going in for her second dose.
very swollen arm, large lump in armpit and swelling in the rest of the armpit area. Ear tenderness and blocked ear All left side
stroke; Joint pain; In the palm of my hand I might jump out of my skin; ; arm was hardly sore at all; right arm at the shoulder, elbow, and fingers is hurting at the joints; This is a spontaneous report from a contactable consumer. This 67-year-old  male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL9269) single dose, dose 1 via unknown route of administration in the left arm for COVID-19 vaccination on 12Feb2021 at 14:30. There were no additional vaccines administered on the same date as the COVID-19 vaccine. Medical history included pneumonia five times on an unknown date, septicemia one time, melanoma cancer in 2015, Factor V Leiden, high blood pressure and blood thinner. Prior Vaccinations (within 4 weeks): Concomitant medications included lisinopril from 2008 and ongoing for high blood pressure and warfarin 9.5 mg daily from 2008  and ongoing for blood thinner. The patient did not receive  any other vaccine within 4 weeks prior to the vaccine. On an unknown date, the patient's arm was hardly sore at all and he had a stroke. On 13Feb2021, the patient experienced joint pain, in the palm of his hand if he presses right in the dead center he thinks he is going to jump out of the skin and right arm at the shoulder, elbow and fingers is hurting at the joints. When he first felt it in his right arm it wasn't horrible and it seemed like it got worse the next day. Then it seemed like it tapered off a little bit. On 16Feb2021, the pain woke him up in the middle of the night. The events did not require an emergency room or physician's office visit. He gets the flu shot every year and he has no symptoms whatsoever. The clinical outcome of stroke, joint pain, in the palm of my hand I might jump out of my skin, arm was hardly sore at all and right arm at the shoulder, elbow, and fingers is hurting at the joints were unknown.
cannot ambulate and lift arm; Entire left side including breast, leg , arm myofacitis, can not ambulate and lift arm, cannot sleep more than 3 hrs due to pain; Paresthesia left leg; cannot sleep more than 3 hrs due to pain; cannot ambulate and lift arm; Entire left side including breast, leg , arm myofacitis; Entire left side including breast, leg , arm myofacitis, cannot ambulate and lift arm, cannot sleep more than 3 hrs due to pain; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 81 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Feb2021 (Lot number: 6N6203) at the age of 81 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "known allergies: Kiwi" (unspecified if ongoing), notes: known allergies: Kiwi. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: 6L8982, Location of injection: Arm Left), administration date: 01Feb2021, when the patient was 81 years old, for COVID-19 Immunization. The following information was reported: LIMB DISCOMFORT (non-serious), GAIT DISTURBANCE (non-serious) all with onset 24Feb2021, outcome "recovered with sequelae" and all described as "cannot ambulate and lift arm"; PAIN (non-serious) with onset 24Feb2021, outcome "recovered with sequelae", described as "Entire left side including breast, leg , arm myofacitis, can not ambulate and lift arm, cannot sleep more than 3 hrs due to pain"; PARAESTHESIA (non-serious) with onset 24Feb2021, outcome "recovered with sequelae", described as "Paresthesia left leg"; SLEEP DEFICIT (non-serious) with onset 24Feb2021, outcome "recovered with sequelae", described as "cannot sleep more than 3 hrs due to pain"; MYOFASCITIS (non-serious) with onset 24Feb2021, outcome "recovered with sequelae", described as "Entire left side including breast, leg , arm myofacitis"; HYPOAESTHESIA (non-serious) with onset 24Feb2021, outcome "recovered with sequelae", described as "Entire left side including breast, leg , arm myofacitis, cannot ambulate and lift arm, cannot sleep more than 3 hrs due to pain". The events "cannot ambulate and lift arm", "entire left side including breast, leg , arm myofacitis, can not ambulate and lift arm, cannot sleep more than 3 hrs due to pain", "paresthesia left leg", "cannot sleep more than 3 hrs due to pain", "cannot ambulate and lift arm", "entire left side including breast, leg , arm myofacitis" and "entire left side including breast, leg , arm myofacitis, cannot ambulate and lift arm, cannot sleep more than 3 hrs due to pain" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of limb discomfort, pain, paraesthesia, sleep deficit, gait disturbance, myofascitis, hypoaesthesia.  No follow-up attempts are possible. No further information is expected.
10/8/22 pt had a positive COVID test; hospitalized; given Decadron, Remdesivir; stabilized and was dc'd to SNF; 10/20-10/24/22 back in hospital with difficulty breathing; worsening O2 requirements over 20L @ 100% O2 Vapotherm and still hypoxic with O2 saturations at 80%; pt terminal; dc'd to Hospice, where he passed away
Flushed/warm skin, nausea and dizzy after 15mins of the vaccine.
Employee felt achey and was feverish, dizzy and nauseated. Also tingling in her face and hands.
Lt thigh 1 cm firm, mobile, NT lump; no redness, FROM on hip and knee; pt walks alone.
tiredness; stomach; This case was reported by a consumer via interactive digital media and described the occurrence of tiredness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2021-2022 season) for prophylaxis.   In September 2021, the patient received Shingles vaccine and Influenza vaccine Quadrivalent 2021-2022 season. On an unknown date, less than 2 weeks after receiving Shingles vaccine and Influenza vaccine Quadrivalent 2021-2022 season, the patient experienced tiredness and stomach discomfort. On an unknown date, the outcome of the tiredness and stomach discomfort were not recovered/not resolved.   It was unknown if the reporter considered the tiredness and stomach discomfort to be related to Shingles vaccine and Influenza vaccine Quadrivalent 2021-2022 season.  Additional details provided were as follows: The case was reported by patient himself/herself. Age at vaccination was not reported. The patient received a shot of Shingles and Flu shot at the same time almost 2 weeks ago of reporting date, it was though not recommended. The patient experienced stomach discomfort and some tiredness and still felt some of the effects of them both. Follow-up would not be possible as no contact details available.
Diffuse Myalgias, chills, low grade fever requiring Tylenol day after vaccination.  Now resolved.   Round, erythematous, flat, tender area on arm about 2 cm inferior to injection site. First noticed 3 days after vaccination.
Information has been received from a registered nurse concerning a female, "between the ages of 16 to 17 years of age", who in August 2007, was vaccinated with a first dose of Gardasil vaccine. Subsequently, after the vaccination the patient became "jittery." At the time of the report, the patient was recovering. No product quality complaint was involved. Additional information has been requested.
I first noticed a buzzing in my ears on February 28th driving home from out of town.  My wife said she had static-like noises and asked me if I heard it too.  She thought there might be something wrong with our car radio.  I said I did, so she turned off the radio to see if it would go away, but we both still heard it.  We have both had this symptom several times since then, often at the same time but not always.
Outpatient adult male who spiked fever 101.5 on 08/23/2012 after receiving flu vaccine in left deltoid IM and Pneumovax vaccine SQ in the left upper lateral brachus on 8/22/2012; Noted discomfort, swelling and redness in left upper arm on 08/24/12 and progressive worsening of symptoms.  Arrived afebrile on 8/25/2012 in clinic at approx 09:45 AM with an erythemic region on left upper arm on the lateroposterior aspect of the upper arm measuring 18 X 19 CM of erythema and angioedema with induration.  Demonstated moderaterate tenderness with tactile stimulation.
Woke up at 2:00AM morning after vaccine with strong fever/chilling Felt very febrile for next two days (48hr) and had very achy body for 3 days after vaccine.  Acute soreness at site of vaccination for about a week.